ARTICLE | Distillery Therapeutics
Cancer
December 5, 2017 7:35 PM UTC
Patient sample, cell culture and mouse studies suggest chimeric antigen receptor (CAR) T cells targeting ANTXR1 could help treat triple-negative breast cancer (TNBC). In patient samples, levels of ANT...
BCIQ Company Profiles
BCIQ Target Profiles